47	85	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'Parvin interactions'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'Parvin proteins do not possess intrinsic catalytic activities'}, {'start':(1, 8), 'end':(1, 20), 'text':'and therefore their functions are mediated through interactions with various binding partners .'}]}]}, {'start':(2, 0), 'end':(2, 12), 'text':'One of the key parvin binding partners is ILK [ - ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 14), 'text':'PARVA and PARVB have clearly been demonstrated to interact with ILK by different binding assays'}, {'start':(3, 15), 'end':(3, 29), 'text':'including yeast two-hybrid , co-immunoprecipitation and glutathione Stransferase ( GST ) fusion pull-down assays .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 15), 'text':'The ILK binding site has been mapped to the CH2 domain of PARVA and PARVB .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 15), 'text':'F271 within this domain appears to be critical for the ILK binding activity of PARVA ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 16), 'end':(5, 23), 'text':'as a single point mutation at this position'}, {'start':(5, 24), 'end':(5, 34), 'text':'( F271D ) abolished its interaction with ILK [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 10), 'text':'Although the CH2 domain is sufficient for interacting with ILK ,'}, {'start':(6, 11), 'end':(6, 24), 'text':'residues located outside of the CH2 domain can modulate the interaction with ILK .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 15), 'text':'The N-terminus of PARVA contains multiple proline directed Ser and Thr phosphorylation sites [ ] .'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 9), 'text':'Deletion of 22 residues from the N-terminus of PARVA inhibits'}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 10), 'end':(8, 18), 'text':'the proline directed Ser and Thr phosphorylation of PARVA'}, {'start':(8, 19), 'end':(8, 28), 'text':'and reduces its complex formation with ILK [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 23), 'text':'On the other side of the binding interface , the parvin binding site has been mapped to the C-terminal kinase domain of ILK .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 13), 'text':'The binding of PARVA and PARVB to ILK is mutually exclusive [ ] ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 14), 'end':(10, 14), 'text':'suggesting'}, {'start':(10, 15), 'end':(10, 33), 'text':'that a single CH2 binding site in the ILK C-terminal domain mediates the interactions with PARVA and PARVB .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 5), 'text':'ILK contains a PH like motif'}, {'start':(11, 6), 'end':(11, 14), 'text':'that partially overlaps with the C-terminal kinase domain .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 12), 'text':'The PH like motif can interact with certain phospholipids such as PIP3 ,'}, {'start':(12, 13), 'end':(12, 21), 'text':'which is produced by the action of PI3-kinase .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 12), 'text':'The PI3-kinase signaling pathway appears important for regulation of the ILK-PARVA interaction ,'}, {'start':(13, 13), 'end':(13, 29), 'text':'since PI3-kinase inhibition or overexpression of the PIP3 phosphatase PTEN can reduce the interaction [ ] .'}]}, {'start':(14, 0), 'end':(14, 21), 'text':'However , deletion of amino acid residues 180-190 within the PH like motif does not inhibit the PARVA interaction [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 26), 'text':'In addition to binding PARVA or PARVB through the C-terminal domain , ILK interacts with PINCH-1 and PINCH-2 , members of a family of focal adhesion proteins'}, {'start':(15, 27), 'end':(15, 45), 'text':'that consist of five LIM domains , through the N-terminal ankyrin repeat domain of ILK [ - ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 15), 'text':'Through these interactions , PINCH , ILK and parvin proteins form ternary complexes in cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 4), 'text':'The formation of the PINCH-ILK-parvin'}, {'start':(17, 5), 'end':(17, 16), 'text':'complexes occurs prior to their localization to cell-matrix adhesions [ ] .'}]}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 15), 'text':'One important consequence of the formation of the PINCH-ILKparvin complexes is the stabilization of these proteins'}, {'start':(18, 16), 'end':(18, 24), 'text':'by protecting them from proteosomal degradation [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 13), 'text':'Furthermore , formation of the PINCH-ILK-parvin complexes facilitates their localization to cell-matrix adhesions .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 18), 'text':'Interestingly , treatment of cells with calphostin C dramatically inhibits the formation of the PINCH-ILKparvin complexes [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 19), 'end':(20, 25), 'text':'suggesting a role of protein kinase C'}, {'start':(20, 26), 'end':(20, 39), 'text':'( PKC ) or other calphostin C responsive signaling pathways in this process .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 1), 'text':'Another interaction'}, {'start':(21, 2), 'end':(21, 16), 'text':'mediated by PARVA is that with paxillin , an important component of focal adhesions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 27), 'text':'Nikolopoulos et al. have mapped the paxillin binding site to amino acids 273-290 of PARVA and the PARVA binding sites to LD1 and LD4 motifs of paxillin .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 13), 'text':'Interestingly , paxillin also interacts with ILK through the LD1 motif [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 20), 'text':'The interactions of paxillin with ILK and PARVA likely contribute to the localization of the PINCH-ILK-parvin complexes to focal adhesions .'}, {'start':(25, 0), 'end':(25, 14), 'text':'In addition to interacting with ILK and paxillin , PARVA can interact with F-actin .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 6), 'text':'PARVA binds to F-actin with an affinity'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 7), 'end':(26, 17), 'text':'that is comparable to those of many other actin binding proteins'}, {'start':(26, 18), 'end':(26, 26), 'text':'( Kd = 8.4 microM ) [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 17), 'text':'Detailed characterization of the F-actin binding sites in the CH domains of PARVA remains to be done .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 7), 'text':'Recently , Lalonde et al. [ ] showed'}, {'start':(28, 8), 'end':(28, 19), 'text':'that PARVA binds to testicular protein kinase 1 ( TESK1 ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 3), 'text':'TESK1 can phosphorylate cofilin'}, {'start':(29, 4), 'end':(29, 14), 'text':'and promote F-actin polymerization and cell spreading [ - ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 5), 'text':'Interestingly , PARVA binds to TESK1'}, {'start':(30, 6), 'end':(30, 12), 'text':'and inhibits its activity [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 15), 'text':'RNA interference ( RNAi ) - mediated depletion of PARVA promotes cell spreading [ ] .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 4), 'text':'PARVA likely suppresses cell spreading'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 5), 'end':(32, 10), 'text':'by regulating multiple signaling pathways ,'}, {'start':(32, 11), 'end':(32, 24), 'text':'including suppression of Rac1 activation [ ] and inhibition of TESK1 [ ] .'}]}]}, {'start':(33, 0), 'end':(33, 12), 'text':'As mentioned above , PARVB , like PARVA , interacts with ILK .'}]}, {'start':(34, 0), 'end':(34, 21), 'text':'However , despite the structural similarity and extensive efforts , PARVB has not been demonstrated to bind to actin or paxillin .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 6), 'text':'Yamaji et al. [ ] recently demonstrated'}, {'start':(35, 7), 'end':(35, 16), 'text':'that PARVB interacts with alpha-actinin via the CH2 domain .'}]}, {'start':(36, 0), 'end':(36, 30), 'text':'In addition , PARVB interacts with alphaPIX [ ] , a guanine nucleotide exchange factor ( GEF ) for Rac1 and possibly other Rho GTPases , through its CH1 domain .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 15), 'text':'PARVB likely functions in actin cytoskeletal remodeling and cell spreading via interactions with multiple partners ,'}, {'start':(37, 16), 'end':(37, 22), 'text':'including ILK , alpha-actinin and alphaPIX .'}]}]}]}
8	17	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'The actin cytoskeleton plays a critical role'}, {'start':(1, 7), 'end':(1, 11), 'text':'in maintaining cellular shape ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 12), 'end':(1, 14), 'text':'regulating cell motility'}, {'start':(1, 15), 'end':(1, 20), 'text':'and responding to mechanical strain .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 3), 'text':'It is highly dynamic'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 4), 'end':(2, 24), 'text':'and responds to extracellular stimuli , such as hormones and growth factors , cell-cell adhesion and variations in the extracellular matrix'}, {'start':(2, 25), 'end':(2, 28), 'text':'( ECM ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 10), 'text':'Cell-ECM adhesion is mediated primarily by integrins and associated proteins .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 15), 'text':'Integrins function as transmembrane receptors for ECM proteins such as fibronectin , laminin and collagen .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 2), 'text':'Through protein complexes'}, {'start':(5, 3), 'end':(5, 11), 'text':'associated with their cytoplasmic domain , such as those'}]}, {'start':(5, 12), 'end':(5, 36), 'text':'containing talin , integrin linked kinase ( ILK ) , PINCH , parvin , paxillin and and or focal adhesion kinase ( FAK ) ,'}]}, {'start':(5, 37), 'end':(5, 48), 'text':'integrins transduce bi-directional signals between the ECM and intracellular signaling pathways .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 16), 'text':'Integrin associated proteins can integrate cell adhesion mediated signaling with other extracellular signals , such as those'}, {'start':(6, 17), 'end':(6, 30), 'text':'originating from growth factor receptors , through a variety of intracellular signaling pathways .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 22), 'text':'In addition to regulating cell survival , proliferation and gene expression , integrin mediated signaling often results in changes in the actin cytoskeleton'}, {'start':(7, 23), 'end':(7, 30), 'text':'leading to cell shape change and motility .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 17), 'text':'In this article , we will review current knowledge about a family of proteins , the parvins ,'}, {'start':(8, 18), 'end':(8, 36), 'text':'which play a critical role in transducing signals from integrins to the actin cytoskeleton and intracellular signaling proteins .'}]}]}]}]}]}]}]}
17	42	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'Structural features'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'The mammalian parvin protein family has three members'}, {'start':(1, 8), 'end':(1, 16), 'text':'( alpha - , beta- and gamma-parvin ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'They were identified independently at approximately the same time by several laboratories'}, {'start':(2, 12), 'end':(2, 21), 'text':'based on their protein binding activities or sequence homology .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 30), 'text':'Approximately 5 years ago , Nikolopoulos and Turner [ ] identified and cloned a new F-actin and paxillin LD1 motif binding protein from a rat complementary DNA ( cDNA ) library'}, {'start':(3, 31), 'end':(3, 35), 'text':'and named it actopaxin .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 22), 'text':'In a yeast two-hybrid screening of ILK binding partners , Tu et al. [ ] identified and cloned a new ILK binding protein'}, {'start':(4, 23), 'end':(4, 34), 'text':'that contains two CH domains and hence named it Calponin Homology domain'}]}, {'start':(4, 35), 'end':(4, 41), 'text':'containing ILK Binding Protein or CH-ILKBP .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 7), 'text':'In an independent yeast two hybrid screening ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 8), 'end':(5, 13), 'text':'Yamaji et al. [ ] identified'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 14), 'end':(5, 18), 'text':'and cloned another new protein'}, {'start':(5, 19), 'end':(5, 23), 'text':'that interacts with ILK ,'}]}, {'start':(5, 24), 'end':(5, 28), 'text':'which they named affixin .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 23), 'text':'Based on sequence homology with the actin binding domain of alpha-actinin , Olski et al. [ ] identified and cloned three structurally related proteins'}, {'start':(6, 24), 'end':(6, 35), 'text':'and named them alpha - , beta- and gamma-parvin , respectively .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 8), 'text':'A comparison of the DNA and protein sequences shows'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 9), 'end':(7, 18), 'text':'that actopaxin and CH-ILKBP are identical to the alpha member'}, {'start':(7, 19), 'end':(7, 31), 'text':'and affixin is identical to the beta member of the parvin family .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 22), 'text':'The members of the parvin family are encoded by three different genes ( parva , parvb and parvg ) in mammalian organisms .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 0), 'text':'Proteins'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(9, 1), 'end':(9, 17), 'text':'that are structurally and functionally related to parvins have been identified in invertebrates such as Caenorhabditis elegans'}, {'start':(9, 18), 'end':(9, 29), 'text':'by sequence analyses [ ] and independent genetic studies [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 9), 'text':'Thus , Parvin appears to be an ancient protein family'}, {'start':(10, 10), 'end':(10, 16), 'text':'and is well conserved during evolution .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 28), 'text':'Human PARVA , PARVB and PARVG contain 372 , 364 and 331 amino acids ( with theoretical molecular masses of 42,330 , 41,770 and 37,485 ) , respectively .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 10), 'text':'In addition , PARVB transcript has two alternative initiation sites ,'}, {'start':(12, 11), 'end':(12, 31), 'text':'which result in proteins of 350 and 313 amino acids ( with theoretical molecular masses of 40,130 and 35,924 ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 18), 'text':'The shorter forms of PARVB are herein respectively abbreviated as PARVB-s and PARVB-ss in contrast with full-length PARVB-l .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 14), 'text':'In human rhabdomyosarcoma cells , an additional alternatively spliced isoform of PARVB was identified ,'}, {'start':(14, 15), 'end':(14, 19), 'text':'named CLINT [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 7), 'text':'This isoform originates from an alternative upstream exon'}, {'start':(15, 8), 'end':(15, 22), 'text':'coding for 70 amino acids and results in a protein with 397 amino acids .'}]}, {'start':(16, 0), 'end':(16, 14), 'text':'For a comprehensive study of the genomic organization of the parvins see [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 29), 'text':'Human PARVA and PARVB share 74 % identity and 85 % similarity , whereas the more distantly related PARVG shares 42 % identity and 67 % similarity with PARVA .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 12), 'text':'The most distinct feature of parvins is the presence of two calponin homology'}, {'start':(18, 13), 'end':(18, 21), 'text':'( CH ) domains in their C-terminal regions ,'}]}, {'start':(18, 22), 'end':(18, 26), 'text':'named CH1 and CH2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 8), 'text':'Each CH domain comprises approximately 100 amino acids ,'}, {'start':(19, 9), 'end':(19, 15), 'text':'separated by a 60-amino acid linker .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 7), 'text':'These CH domains are considered \' atypical \''}, {'start':(20, 8), 'end':(20, 42), 'text':'in that they do not exactly match the consensus sequences of type 1 and type 2 CH domains present in a large number of actin binding proteins such as alpha-actinin , spectrin and filamin .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 15), 'text':'The parvin CH1 domain is more related to the type 1 CH domain of spectrin ,'}, {'start':(21, 16), 'end':(21, 32), 'text':'whereas the second CH domain is more related to the type 1 CH domain of alpha-actinin .'}]}, {'start':(22, 0), 'end':(22, 23), 'text':'The CH1 and CH2 domains of the parvins are tentatively classified as type 4 and type 5 CH domains , respectively [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 19), 'text':'In addition to the conserved CH domains , the parvins have a 60-amino acid linker with some homology to regions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 20), 'end':(23, 32), 'text':'preceding the CH1 of beta-spectrin and plectin , as well as N-terminal extensions'}, {'start':(23, 33), 'end':(23, 63), 'text':'that show a high degree of variability between the various parvins , from 82 amino acids in PARVG to 125 amino acids in PARVB and 133 amino acids in PARVA .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 24), 'text':'Both PARVA and PARVB have nuclear localization signals in the N-terminal extensions , as well as src-homology SH3 binding sites of the consensus PXXP ,'}, {'start':(24, 25), 'end':(24, 35), 'text':'where X is any amino acid but cysteine [ ] .'}]}]}]}
126	144	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 3), 'text':'Regulation of Rac1 activation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 14), 'text':'The small G-proteins of the Rho family play a critical role in signal transduction pathways'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 15), 'end':(1, 17), 'text':'connecting integrin signaling'}, {'start':(1, 18), 'end':(1, 23), 'text':'and cytoskeletal dynamics [ ] .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'In particular , Rac1 and Cdc42 promote cell spreading and motility ,'}, {'start':(2, 12), 'end':(2, 20), 'text':'while RhoA promotes formation of actin stress fibers .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 12), 'text':'Rac1 is involved in the formation of wide protrusions , or lamellipodia ,'}, {'start':(3, 13), 'end':(3, 30), 'text':'associated with early events in cellular attachment and spreading , and in certain types of cellular motility .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 16), 'text':'In contrast , Cdc42 is more involved in the formation of thin protrusion , or filopodia .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 5), 'text':'However , considerable overlap and cross'}, {'start':(5, 6), 'end':(5, 14), 'text':'talking occur between these various Rho family members .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'condition', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 10), 'text':'Since both Rac1 and parvins regulate the formation of lamellipodia ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 11), 'end':(6, 15), 'text':'it is of great interest'}, {'start':(6, 16), 'end':(6, 26), 'text':'to study the interaction between integrins/PINCH/ILK / parvins and Rac1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 18), 'text':'Depletion of ILK and PINCH-1 significantly ( 50-55 % ) reduced adhesion dependent activation of Rac1 [ ] .'}, {'label':'contrast', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 14), 'text':'In striking contrast , depletion of PARVA resulted in a significant increase in Rac1 activity'}, {'start':(8, 15), 'end':(8, 20), 'text':'and increased spreading [ ] .'}]}, {'start':(9, 0), 'end':(9, 19), 'text':'In contrast , depletion of PARVB in Hela cells did not increase Rac1 activity and cell spreading [ ] .'}]}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 15), 'text':'In fact , depletion of PARVB in HeLa cells appears to slightly reduce Rac1 activity .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 17), 'text':'Interestingly , overexpression of the CH1 fragment of PARVB in MDCK cells resulted in Rac1 and Cdc42 activation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 18), 'end':(11, 33), 'text':'and increased cell spreading and motility with increased formation of lamellipodia and filopodia , an effect'}, {'start':(11, 34), 'end':(11, 43), 'text':'blocked by dominant negative RacN17 and Cdc42N17 [ ] .'}]}]}]}]}, {'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 25), 'text':'These effects appear to be mediated by interaction of the CH1 domain with aPIX ( ARHGEF6 ) , a GEF activator of Cdc42 and Rac1 ,'}, {'start':(12, 26), 'end':(12, 37), 'text':'since an inactive mutant of ARHGEF6 blocked this effect of CH1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 13), 'text':'Since the interaction of PARVB and aPIX appears to decrease with fulllength PARVB ,'}, {'start':(13, 14), 'end':(13, 18), 'text':'two possibilities are suggested :'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 19), 'end':(13, 26), 'text':'( i ) ILK complexes with PARVB inhibit'}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 27), 'end':(13, 30), 'text':'interaction with alphaPIX ;'}, {'start':(13, 31), 'end':(13, 44), 'text':'and ( ii ) the C-terminus of PARVB inhibits the interaction with alphaPIX .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 11), 'text':'Because the CH2 domain of PARVB can be phosphorylated by ILK ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 12), 'end':(14, 14), 'text':'it is possible'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 15), 'end':(14, 20), 'text':'that this induces a conformational change'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(14, 21), 'end':(14, 25), 'text':'that allows the CH1 domain'}, {'start':(14, 26), 'end':(14, 30), 'text':'to bind to alphaPIX .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 17), 'text':'Alpha-PIX , ILK and PARVB can be found at the leading edge of spreading cells [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 2), 'text':'It is likely'}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 3), 'end':(16, 22), 'text':'that in some cells activation of Rac1 and Cdc42 at the lamellipodia is stimulated by interactions of alphaPIX with PARVB'}, {'start':(16, 23), 'end':(16, 31), 'text':'and regulated by interaction of ILK and PARVB .'}]}]}, {'start':(17, 0), 'end':(17, 21), 'text':'In addition , PINCH , ILK and parvin proteins may regulate Rac activation through other GEFs such as DOCK180 [ ] .'}]}]}]}]}
0	1	{'start':(0, 0), 'end':(0, 1), 'text':'The parvins'}
186	207	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 5), 'text':'Role of parvins in striated muscle'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'In C. elegans , the integrin dependent pathways'}, {'start':(1, 8), 'end':(1, 18), 'text':'involved in myofibrillogenesis have been clarified by forward genetic screens .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'Deposition of the ECM protein perlecan and UNC -52 initiates outside-in signaling'}, {'start':(2, 12), 'end':(2, 19), 'text':'transduced by the integrin receptor , PAT-3 ,'}]}, {'start':(2, 20), 'end':(2, 25), 'text':'which then recruits two complexes :'}]}, {'start':(2, 26), 'end':(2, 47), 'text':'( i ) vinculin and DEB1 , and ( ii ) ILK and PAT -4 + Mig-2 / UNC-112 [ ] .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 12), 'text':'Both of these complexes are required for the formation of rudimentary FAs ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 13), 'end':(3, 26), 'text':'which will become the initial sites of myofibril formation ( the dense bodies )'}, {'start':(3, 27), 'end':(3, 36), 'text':'and subsequently of muscle attachment to the body wall .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 12), 'text':'Maturation of dense bodies involves recruitment of PARVA and PAT -6 and PINCH-1'}, {'start':(4, 13), 'end':(4, 25), 'text':'/ UNC-97 , both of which bind to ILK and PAT -4 ,'}]}, {'start':(4, 26), 'end':(4, 34), 'text':'as determined by yeast three-hybrid assay [ ] .'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 16), 'text':'In addition to this PINCH-ILK-parvin complex , vinculin and talin are required for initiation of myofibril formation'}, {'start':(5, 17), 'end':(5, 24), 'text':'by attracting sarcomeric actin filaments [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 16), 'text':'Alpha-actinin seems to be added to functional dense bodies at a later stage after larval hatching .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 8), 'text':'Recruitment of myosin filaments does not require vinculin ;'}, {'start':(7, 9), 'end':(7, 18), 'text':'instead UNC-89 is required at the M-line [ ] .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 12), 'text':'Interestingly , UNC-89 is the ortologue of an alternatively spliced isoform of obscurin'}, {'start':(8, 13), 'end':(8, 28), 'text':'containing several immunoglobulin domains and a Rho guanidine nucleotide exchange factor ( GEF ) domain .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 11), 'text':'Obscurin and titin co-localize during myofibrillogenesis in cardiac myocytes [ ] ,'}, {'start':(9, 12), 'end':(9, 24), 'text':'and the obscurin-RhoGEF isoform is upregulated during cardiac hypertrophy [ - ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 17), 'text':'Since obscurin interacts with titin at the Z-line [ ] and PARVA-ILK complexes are localized in the costameres'}, {'start':(10, 18), 'end':(10, 23), 'text':'overlapping the Z-line of cardiac myocytes'}]}, {'start':(10, 24), 'end':(10, 33), 'text':'and play a role in myocyte hypertrophy [ ] ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 34), 'end':(10, 36), 'text':'these observations suggest'}, {'start':(10, 37), 'end':(10, 59), 'text':'that modulation of obscurin activity and and or localization by ILK-PARVA complexes may play a role in sarcomere assembly during cardiac hypertrophy .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 8), 'text':'In concordance with the studies in mammalian cells ,'}, {'start':(11, 9), 'end':(11, 31), 'text':'the CH2 domain of PARVA and PAT6 was necessary and sufficient for binding to ILK and for efficient localization to dense bodies .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 8), 'text':'The CH1 domain was dispensable for proper localization ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 9), 'end':(12, 15), 'text':'but it was required for downstream events'}, {'start':(12, 16), 'end':(12, 19), 'text':'leading to myofibrillogenesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 14), 'text':'Recent studies have demonstrated the presence of a PINCH-1-ILK-PARVA complex in neonatal cardiac myocytes ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 15), 'end':(13, 19), 'text':'and its recruitment to costameres'}, {'start':(13, 20), 'end':(13, 39), 'text':'associated with the Z-disks of newly formed sarcomeres in response to hypertrophic stimulation with fibronectin and phenylephrine [ ] .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 5), 'text':'A dominant negative mutant of ILK'}, {'start':(14, 6), 'end':(14, 8), 'text':'lacking PINCH-1 binding'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 9), 'end':(14, 18), 'text':'( ILK-C ) removed ILK and PARVA from costamere locations'}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 19), 'end':(14, 23), 'text':'and induced mild hypertrophy ,'}, {'start':(14, 24), 'end':(14, 27), 'text':'while promoting apoptosis .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 10), 'text':'These observations suggest a role for PARVA in promoting cell survival'}, {'start':(15, 11), 'end':(15, 18), 'text':'and inhibiting hypertrophy in the cardiac myocyte .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 19), 'text':'Since PARVA inhibits Rac1 activity and this small G protein plays a critical role in cardiac hypertrophy [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 20), 'end':(16, 25), 'text':'we are currently investigating the possibility'}, {'start':(16, 26), 'end':(16, 41), 'text':'that PARVA and other ILK complexes regulate the level of Rac1 activity in cardiac myocytes .'}]}]}, {'start':(17, 0), 'end':(17, 21), 'text':'PARVB and ILK co-localized at regions of the sarcolemma corresponding to the Z-disk in skeletal muscle ( costameres ) [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 5), 'text':'In another study , PARVB co-localized'}, {'start':(18, 6), 'end':(18, 21), 'text':'and interacted with the sarcolemmal protein , dysferlin , in human skeletal muscle [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 12), 'text':'The sarcolemmal localization of PARVB was reduced in muscle dystrophy with dysferlin mutations'}, {'start':(19, 13), 'end':(19, 23), 'text':'and may indicate a role for PARVB in membrane integrity .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 2), 'text':'Taken together ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 3), 'end':(20, 5), 'text':'these results suggest'}, {'start':(20, 6), 'end':(20, 19), 'text':'that parvin proteins may play both physical and signaling roles in muscle cells .'}]}]}]}]}]}
85	110	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'Subcellular Localization'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'When cells attach to the ECM ,'}, {'start':(1, 7), 'end':(1, 15), 'text':'several changes occur at the membrane and cytoskeleton .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'First , nascent cell-ECM contacts ( focal complexes ) are established ,'}, {'start':(2, 12), 'end':(2, 41), 'text':'where integrins engage with the ECM and recruit proteins , such as talin , paxillin , PINCH , ILK , parvins , alpha-actinin , vinculin , FAK and VASP .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 15), 'text':'This leads to recruitment of additional F-actin and F-actin associated proteins and maturation into focal adhesions'}, {'start':(3, 16), 'end':(3, 19), 'text':'( FAs ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 7), 'text':'In addition to the establishment of FAs ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(4, 8), 'end':(4, 15), 'text':'spreading cells will extend wide membrane protrusions ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 16), 'end':(4, 23), 'text':'called lamellipodia , also present in some cells'}, {'start':(4, 24), 'end':(4, 27), 'text':'initiating directional migration .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 11), 'text':'Soon after identification of parvins as ILK and paxillin binding proteins ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 12), 'end':(5, 14), 'text':'it became apparent'}, {'start':(5, 15), 'end':(5, 30), 'text':'that protein protein interactions of parvins with these partners were critical for their subcellular localization .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 35), 'text':'More specifically , the formation of complexes of ILK with parvins and the LIM proteins PINCH-1 and PINCH-2 became a paradigm for multiprotein complex formation , stabilization and localization in the context of cell adhesion .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 16), 'text':'Both PARVA and PARVB , together with ILK , are observed in lamellipodia in spreading cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(7, 17), 'end':(7, 19), 'text':'although it appears'}, {'start':(7, 20), 'end':(7, 45), 'text':'that ILK , PARVB and PINCH-1 are expressed very early at the plasma membrane during lamellipodia extension before FAK , vinculin and paxillin are recruited .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 8), 'text':'Established FAs clearly contain both PARVA and PARVB .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 27), 'text':'In addition to FAs and lamellipodia , ILK , PINCH and PARVA staining is observed in a fibrillar pattern more intense towards the center of the cells .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 0), 'text':'PARVA'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 1), 'end':(10, 3), 'text':'containing central fibers'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 4), 'end':(10, 6), 'text':'correspond to tensin'}, {'start':(10, 7), 'end':(10, 12), 'text':'containing fibrillar adhesions [ ] .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 7), 'text':'Tensin containing fibrillar adhesions are highly dynamic structures'}, {'start':(11, 8), 'end':(11, 14), 'text':'that overlay fibronectin fibrils in the ECM'}]}, {'start':(11, 15), 'end':(11, 25), 'text':'and move towards the center through the action of actomyosin .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 14), 'text':'Localization of PARVA to epithelial cell-cell adhesion junctions , rich in cadherins and catenins ,'}, {'start':(12, 15), 'end':(12, 28), 'text':'has been observed in some epithelial cells [ ] but not in others ,'}]}, {'start':(12, 29), 'end':(12, 34), 'text':'possibly indicating some cell-type specificity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 8), 'text':'PARVB has been found associated with thin stress fibers'}, {'start':(13, 9), 'end':(13, 15), 'text':'( involved in lamellipodia protrusion ) ,'}]}, {'start':(13, 16), 'end':(13, 21), 'text':'where it co-localizes with alpha-actinin ,'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 22), 'end':(13, 28), 'text':'but is excluded from mature stress fibers'}, {'start':(13, 29), 'end':(13, 36), 'text':'( involved in maintaining cell architecture ) ,'}]}, {'start':(13, 37), 'end':(13, 44), 'text':'where alpha-actinin crosslinks actin filaments [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 13), 'text':'The domains responsible for the various subcellular localizations of PARVA and PARVB were investigated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 14), 'end':(14, 20), 'text':'by transfecting cells with various parvin mutants'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 21), 'end':(14, 25), 'text':'fused to green fluorescent protein'}, {'start':(14, 26), 'end':(14, 29), 'text':'( GFP ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 3), 'text':'In general the GFP'}, {'start':(15, 4), 'end':(15, 7), 'text':'fused full sized parvins'}]}, {'start':(15, 8), 'end':(15, 13), 'text':'co-localized with their endogenous counterparts .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'Using this method ,'}, {'start':(16, 4), 'end':(16, 25), 'text':'localization to FAs and fibrillar adhesions was determined to depend on the CH2 domains of both PARVA and PARVB [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 9), 'text':'The CH2 domain alone was sufficient for FA localization ,'}, {'start':(17, 10), 'end':(17, 22), 'text':'although the other regions appear to increase the intensity of FA localization .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 15), 'text':'A single point mutation ( F271D ) in the CH2 domain of PARVA , a residue'}, {'start':(18, 16), 'end':(18, 20), 'text':'also conserved in PARVB ,'}]}, {'start':(18, 21), 'end':(18, 29), 'text':'is sufficient to abolish FA localization [ ] .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 15), 'text':'Mutations in the putative paxillin binding site ( PBS , amino acids 273-290 of PARVA )'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(19, 16), 'end':(19, 19), 'text':'also abolish FA localization'}, {'start':(19, 20), 'end':(19, 24), 'text':'without affecting ILK binding .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 19), 'text':'Thus , the interaction with ILK is likely necessary but not sufficient for efficient localization of PARVA to FAs .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 7), 'text':'A mutant of ILK ( F438A ) ,'}, {'start':(21, 8), 'end':(21, 14), 'text':'which does not affect PARVA binding ,'}]}, {'start':(21, 15), 'end':(21, 21), 'text':'is unable to localize to FAs ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(21, 22), 'end':(21, 22), 'text':'indicating'}, {'start':(21, 23), 'end':(21, 36), 'text':'that other interactions are also necessary for FA localization of ILK [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 10), 'text':'Since this site is away from the paxillin binding region ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(22, 11), 'end':(22, 14), 'text':'it is more likely'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(22, 15), 'end':(22, 24), 'text':'that additional proteins , such as Mig-2 or integrins ,'}, {'start':(22, 25), 'end':(22, 39), 'text':'are also involved in recruitment of the ILK and PARVA complex to the FAs .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 22), 'text':'Since the binding between PARVA and ILK appears stronger than that between ILK and paxillin and the ILK and PARVA complex is formed'}, {'start':(23, 23), 'end':(23, 31), 'text':'even in cells without cell-matrix contacts [ ] ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 32), 'end':(23, 35), 'text':'we favor a model'}, {'start':(23, 36), 'end':(23, 52), 'text':'whereby PINCH-1 , ILK and PARVA form a complex prior to their localization to cell-matrix adhesions .'}]}]}]}]}]}]}]}]}]}, {'start':(24, 0), 'end':(24, 28), 'text':'The formation of the PINCH-1-ILK-PARVA complex allows it to be recruited to FAs via interactions with multiple FA proteins such as integrins , paxillin and and or Mig-2 .'}]}]}]}]}]}
1	8	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'Abstract .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'The parvins are a family of proteins'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 7), 'end':(1, 10), 'text':'involved in linking integrins'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 11), 'end':(1, 16), 'text':'and associated proteins with intracellular pathways'}, {'start':(1, 17), 'end':(1, 25), 'text':'that regulate actin cytoskeletal dynamics and cell survival .'}]}]}]}, {'start':(2, 0), 'end':(2, 46), 'text':'Both alpha-parvin ( PARVA ) and beta-parvin ( PARVB ) localize to focal adhesions and function in cell adhesion , spreading , motility and survival through interactions with partners , such as integrin linked kinase ( ILK ) , paxillin , alpha-actinin and testicular kinase 1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 21), 'text':'A complex of PARVA with ILK and the LIM protein PINCH-1 is critical for cell survival in a variety of cells ,'}, {'start':(3, 22), 'end':(3, 32), 'text':'including certain cancer cells , kidney podocytes and cardiac myocytes .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 14), 'text':'While PARVA inhibits the activities of Rac1 and testicular kinase 1 and cell spreading ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 15), 'end':(4, 20), 'text':'PARVB binds alphaPIX and alpha-actinin ,'}, {'start':(4, 21), 'end':(4, 26), 'text':'and can promote cell spreading .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 8), 'text':'In contrast to PARVA , PARVB inhibits ILK activity'}, {'start':(5, 9), 'end':(5, 19), 'text':'and reverses some of its oncogenic effects in cancer cells .'}]}, {'start':(6, 0), 'end':(6, 18), 'text':'This review focuses on the structure and function of the parvins and some possible roles in human diseases .'}]}]}
144	171	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 7), 'text':'Role of parvins in cell spreading and motility'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 28), 'text':'The localization of both PARVA and PARVB at FAs as well as in the leading edge of lamellipodia suggests a role for these proteins in regulating cell adhesion ,'}, {'start':(1, 29), 'end':(1, 32), 'text':'spreading and motility .'}]}]}, {'start':(2, 0), 'end':(2, 23), 'text':'Table summarizes studies on the function of parvin , ILK and PINCH proteins in cell adhesion , spreading , motility and actin polymerization .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 3), 'text':'These studies have demonstrated'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 4), 'end':(3, 16), 'text':'that ILK , PINCH-1 , PARVA and PARVB complexes modulate early cellular events'}, {'start':(3, 17), 'end':(3, 22), 'text':'triggered by interaction with ECM ,'}]}, {'start':(3, 23), 'end':(3, 37), 'text':'including formation and and or turnover of FA , actin dynamics and protrusion of lamellipodia'}]}, {'start':(3, 38), 'end':(3, 44), 'text':'to promote cellular spreading and motility .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 17), 'text':'More specifically , ILK and PINCH-1 are required for all of these processes , since depletion with small'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 18), 'end':(4, 19), 'text':'interfering RNAs'}, {'start':(4, 20), 'end':(4, 26), 'text':'( siRNAs ) significantly inhibit them .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 8), 'text':'The role of the parvins is more complex .'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 5), 'text':'Based on their subcellular localization ,'}, {'start':(6, 6), 'end':(6, 16), 'text':'PARVB appears to play an earlier role in lamellipodia formation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 21), 'text':'Consistent with an early role in cell adhesion , depletion of PARVB with siRNA caused inhibition of lamellipodia formation [ ] .'}, {'start':(8, 0), 'end':(8, 12), 'text':'In contrast , depletion of PARVA actually increased cell spreading [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'condition', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'As we discussed above ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 5), 'end':(9, 21), 'text':'this observation is consistent with the respective roles of PARVA and PARVB in modulating Rac1 activity ,'}, {'start':(9, 22), 'end':(9, 38), 'text':'which is critical for lamellipodia formation , with PARVA inhibiting and PARVB possibly promoting Rac1 activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 14), 'text':'In addition , PARVA suppresses cell spreading through inhibition of TESK1 activity [ ] .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 5), 'text':'It will be interesting to test'}, {'start':(11, 6), 'end':(11, 16), 'text':'whether PARVB plays an opposite role in regulation of TESK1 .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 4), 'text':'As we have discussed ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 5), 'end':(12, 10), 'text':'phosphorylation of PARVA regulates its function'}, {'start':(12, 11), 'end':(12, 16), 'text':'and enhances PINCH-ILK-PARVA complex formation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 9), 'text':'Interestingly , cell adhesion to fibronectin promotes PARVA phosphorylation ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 10), 'end':(13, 17), 'text':'which could dissociate the active TESK1 from PARVA'}, {'start':(13, 18), 'end':(13, 29), 'text':'and contribute to an increase of actin polymerization and cell spreading .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 18), 'text':'Consistent with these observations , overexpression of unphosphorylatable PARVA mutants ( by deletion or mutation of N-terminal sites )'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(14, 19), 'end':(14, 28), 'text':'acted as dominant negative inhibitor of cell spreading , presumably'}, {'start':(14, 29), 'end':(14, 39), 'text':'by staying locked into an inactive TESK1 complex [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 13), 'text':'Similarly , overexpression of the CH2 domain of PARVA also inhibited cell spreading ,'}, {'start':(15, 14), 'end':(15, 19), 'text':'despite proper localization to FAs .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 7), 'text':'It is unclear whether CH1 interacting proteins ,'}, {'start':(16, 8), 'end':(16, 16), 'text':'equivalent to the binding of ARHGEF6 to PARVB ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 17), 'end':(16, 20), 'text':'also interact with PARVA'}, {'start':(16, 21), 'end':(16, 28), 'text':'and modulate its function at the FAs .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 17), 'text':'In platelets , an ILK and PARVB complex was rapidly recruited to integrin beta3 upon thrombin stimulation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 18), 'end':(17, 29), 'text':'resulting in a transient increase in ILK activity and phosphorylation of PARVB'}, {'start':(17, 30), 'end':(17, 43), 'text':'followed by translocation of the ILK and PARVB complex to the cytoskeletal fraction ,'}]}, {'start':(17, 44), 'end':(17, 52), 'text':'where it may promote integrin-cytoskeleton interactions [ ] .'}]}]}, {'start':(18, 0), 'end':(18, 14), 'text':'In CHO cells , overexpression of the CH2 domain of PARVB blocked cell spreading .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 12), 'text':'This effect was reversed by cotransfection of ILK with intact kinase activity ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 13), 'end':(19, 13), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 14), 'end':(19, 23), 'text':'that phosphorylation of PARVB by ILK may play a role'}, {'start':(19, 24), 'end':(19, 30), 'text':'in promoting cell spreading [ ] .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(20, 0), 'end':(20, 10), 'text':'The N-terminus of PARVB CH2 domain ( amino acids 249-272 )'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(20, 11), 'end':(20, 38), 'text':'interacts with alpha-actinin ( N-terminal ABD and C-terminal EF-hand domains ) only upon engagement of integrins with the ECM , with a peak at 60 min post-adhesion ,'}, {'start':(20, 39), 'end':(20, 47), 'text':'when cell spreading is most active [ ] .'}]}]}, {'start':(21, 0), 'end':(21, 17), 'text':'The interaction with alpha-actinin required phosphorylation of the CH2 domain of PARVB by ILK upon cell adhesion .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 4), 'text':'Over-expression of a PARVB mutant'}, {'start':(22, 5), 'end':(22, 10), 'text':'containing only amino acids 249-272 ,'}]}, {'start':(22, 11), 'end':(22, 31), 'text':'which can bind alpha-actinin but not ILK , disrupted the PARVB-alpha-actinin interaction and markedly inhibited lamellipodia formation and cell spreading .'}]}]}]}, {'start':(23, 0), 'end':(23, 11), 'text':'This effect was also seen with depletion of PARVB by siRNA .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 12), 'text':'These results , together with results from other studies , suggest a model'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 13), 'end':(24, 28), 'text':'by which a PINCH-ILK-PARVB complex forms at integrin attachment sites in very early membrane blebs ,'}, {'start':(24, 29), 'end':(24, 35), 'text':'where ILK kinase activity is induced ,'}]}, {'start':(24, 36), 'end':(24, 44), 'text':'resulting in phosphorylation of the PARVB CH2 domain .'}]}]}, {'start':(25, 0), 'end':(25, 18), 'text':'PARVB then recruits alpha-actinin ( or stabilizes the integrin-alpha-actinin complex ) to the leading edge of the lamellipodia .'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 10), 'text':'PINCH , ILK , PARVB and alpha-actinin can promote lamellipodia extension'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 11), 'end':(26, 16), 'text':'by attracting actin polymerization complexes ,'}, {'start':(26, 17), 'end':(26, 39), 'text':'including proteins of the Nck and ARP2 and 3 ( through Rac / Cdc42 and WASP ) families [ , - ] .'}]}]}]}]}
171	186	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 8), 'text':'Role of parvins on Akt activation and cell survival'}, {'start':(1, 0), 'end':(1, 13), 'text':'PARVA plays an important role in protection of cells from apoptosis [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 13), 'text':'By contrast , depletion of PARVB in HeLa cells does not induce apoptosis ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 14), 'end':(2, 14), 'text':'indicating'}, {'start':(2, 15), 'end':(2, 24), 'text':'it is not essential for cell survival [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 4), 'text':'PARVA protects cells from apoptosis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 5), 'end':(3, 19), 'text':'by facilitating the activation of Akt ( protein kinase B ) , a key survival'}, {'start':(3, 20), 'end':(3, 22), 'text':'signaling intermediate .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 20), 'text':'In response to cell-matrix adhesion and soluble survival factors such as IGF-1 , inactive Akt is translocated to plasma membrane ,'}, {'start':(4, 21), 'end':(4, 33), 'text':'where it is phosphorylated on T308 and S473 and consequently fully activated .'}]}]}]}]}, {'start':(5, 0), 'end':(5, 11), 'text':'Loss of PARVA impairs the membrane translocation of Akt [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 11), 'text':'Furthermore , expression of a constitutively membrane bound ( myristoylated ) Akt'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 12), 'end':(6, 26), 'text':'( Myr-Akt ) rescued the defects in the activating phosphorylation of Akt and cell survival'}, {'start':(6, 27), 'end':(6, 33), 'text':'induced by the loss of PARVA .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 6), 'text':'Thus , PARVA protects cells from apoptosis'}, {'start':(7, 7), 'end':(7, 16), 'text':'via facilitating the activating phosphorylation of Akt [ ] .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 12), 'text':'ILK depletion also affects Akt phosphorylation and activation in some cell types ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 13), 'end':(8, 15), 'text':'particularly transformed cells'}, {'start':(8, 16), 'end':(8, 20), 'text':'( reviewed in ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 8), 'text':'ILK kinase activity is transiently increased during cell attachment'}, {'start':(9, 9), 'end':(9, 17), 'text':'and enriched in the cytoskeletal fraction [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 11), 'text':'PARVA depleted cells show much lower ILK kinase activity [ ] ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 12), 'end':(10, 12), 'text':'indicating'}, {'start':(10, 13), 'end':(10, 31), 'text':'that the formation of the PARVA and ILK complex also plays a role for the activation of ILK .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 2), 'text':'Mutations in ILK'}, {'start':(11, 3), 'end':(11, 19), 'text':'that abolish the ILK-PARVA interaction also inhibit the ability of ILK to promote Akt S473 phosphorylation .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 4), 'text':'In cells overexpressing PTEN ,'}, {'start':(12, 5), 'end':(12, 13), 'text':'ILK kinase activity and PARVA interaction are inhibited .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 6), 'text':'Transfection of PARVA restores ILK activity ,'}, {'start':(13, 7), 'end':(13, 28), 'text':'as demonstrated by increased ILK kinase activity , GSK3beta S9 phosphorylation , Akt S473 phosphorylation and beta-catenin/TCF/LEF transcriptional activity [ ] .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 15), 'text':'Although ILK and PINCH-1 likely work in concert with PARVA in regulation of Akt phosphorylation ,'}, {'start':(14, 16), 'end':(14, 32), 'text':'Akt is not the only downstream target in ILK and PINCH-1-mediated cell survival signaling [ ] .'}]}]}]}]}
110	126	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 4), 'text':'Functional role of PARVA phosphorylation'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 3), 'text':'As mentioned earlier ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 4), 'end':(1, 19), 'text':'the N-terminal domain of PARVA contains phosphorylation consensus regions for prolinedirected serine and threonine kinase ,'}, {'start':(1, 20), 'end':(1, 24), 'text':'including ERK and Cdc2 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 26), 'text':'The Cdc2 kinase , in combination with cyclin B1 , has been shown to phosphorylate S4 , S8 , S14 and S19 of PARVA [ ] ,'}, {'start':(2, 27), 'end':(2, 38), 'text':'and ERK can also phosphorylate the N-terminus of PARVA [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 16), 'text':'During mitosis , phosphorylation of S4 and S8 by Cdc2 causes gel mobility shift of PARVA .'}, {'start':(4, 0), 'end':(4, 7), 'text':'These sites are not present in PARVB .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 6), 'text':'PARVA phosphorylation increases during cell spreading .'}, {'start':(6, 0), 'end':(6, 14), 'text':'Phosphorylation during cell attachment and spreading appears to depend on ERK activity [ ] .'}]}]}, {'start':(7, 0), 'end':(7, 10), 'text':'ERK is recruited to FAs by paxillin during cell spreading .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 5), 'text':'A quintuple mutant of PARVA ,'}, {'start':(8, 6), 'end':(8, 16), 'text':'in which all four N-terminal serines and T16 were mutated ,'}]}, {'start':(8, 17), 'end':(8, 19), 'text':'was not phosphorylated'}]}, {'start':(8, 20), 'end':(8, 25), 'text':'and functioned as dominant negative ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 26), 'end':(8, 37), 'text':'inhibiting cell spreading and motility but increasing F-actin formation in human osteosarcoma'}, {'start':(8, 38), 'end':(8, 44), 'text':'( U2OS ) cells [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 9), 'text':'In kidney podocytes , overexpression of a PARVA mutant ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(9, 10), 'end':(9, 15), 'text':'in which the Nterminal proline directed'}, {'start':(9, 16), 'end':(9, 21), 'text':'serine phosphorylation sites are deleted ,'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 22), 'end':(9, 27), 'text':'reduced PARVA complex formation with ILK'}, {'start':(9, 28), 'end':(9, 36), 'text':'and inhibited podocyte adhesion , spreading and survival ,'}]}]}, {'start':(9, 37), 'end':(9, 51), 'text':'suggesting an important role of PARVA phosphorylation in regulation of these processes [ ] .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 10), 'text':'The interaction of PARVA with TESK1 is also regulated by proline'}, {'start':(10, 11), 'end':(10, 16), 'text':'directed serine phosphorylation of PARVA .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 4), 'text':'Unphosphorylated PARVA binds to TESK1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 5), 'end':(11, 11), 'text':'and inhibits its activity [ ] ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(11, 12), 'end':(11, 14), 'text':'therefore allowing cofilin'}, {'start':(11, 15), 'end':(11, 21), 'text':'to reduce actin polymerization and spreading .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 16), 'text':'Upon cell adhesion , ERK is activated to increase the phosphorylation at the N-terminus of PARVA ,'}, {'start':(12, 17), 'end':(12, 40), 'text':'leading to release of TESK1 , phosphorylation of cofilin , F-actin polymerization at the lamellipodia , and increased spreading and motility [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 11), 'text':'Interestingly , ILK was not pulled down by GST-TESK1 [ ] ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 12), 'end':(13, 12), 'text':'indicating'}, {'start':(13, 13), 'end':(13, 25), 'text':'that the interactions of PARVA with ILK and TESK1 are mutually exclusive .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 5), 'text':'These results suggest an interesting possibility'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 6), 'end':(14, 10), 'text':'that phosphorylation of PARVA ,'}, {'start':(14, 11), 'end':(14, 46), 'text':'which promotes the complex formation of PARVA with ILK and PINCH [ ] , likely removes the inhibitory effect of PARVA on the interaction with TESK1 and consequently the inhibitory effect on its kinase activity .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 5), 'text':'While the defect in cell spreading'}, {'start':(15, 6), 'end':(15, 20), 'text':'caused by mutation of the N-terminus of PARVA was partially corrected by overexpression of TESK1'}]}, {'start':(15, 21), 'end':(15, 26), 'text':'lacking the PARVA binding site ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 27), 'end':(15, 31), 'text':'the defect in cell spreading'}, {'start':(15, 32), 'end':(15, 47), 'text':'caused by a PBS mutant of PARVA deficient in paxillin binding was not [ ] ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 48), 'end':(15, 48), 'text':'indicating'}, {'start':(15, 49), 'end':(15, 58), 'text':'that PARVA affects cell spreading via multiple signaling pathways .'}]}]}]}]}]}]}
207	238	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 5), 'text':'Role of parvins in pathological processes'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 13), 'text':'Given the importance of the parvins in regulating actin cytoskeleton and survival signaling ,'}, {'start':(1, 14), 'end':(1, 24), 'text':'they are probably involved in a number of pathological processes .'}]}]}, {'start':(2, 0), 'end':(2, 19), 'text':'In particular , recent studies have implicated parvins in two human diseases , namely breast cancer and diabetic nephropathy .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 1), 'text':'Breast cancer'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 6), 'text':'Anchorage independent growth and resistant to apoptosis'}, {'start':(4, 7), 'end':(4, 12), 'text':'induced by loss of integrin-ECM contact'}]}, {'start':(4, 13), 'end':(4, 22), 'text':'( anoikis ) is a hallmark of cancer cells .'}]}]}]}, {'start':(5, 0), 'end':(5, 15), 'text':'Moreover , changes in cell-ECM interaction can lead to increased motility characteristic of metastatic cells .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 13), 'text':'Overexpression of ILK with hyperactive kinase function has been shown to occur in several'}, {'start':(6, 14), 'end':(6, 14), 'text':'transformed'}]}, {'start':(6, 15), 'end':(6, 39), 'text':'epithelial cells [ ] and inhibition of ILK kinase or expression of ILK dominant negative mutants can reverse several features of the transformed phenotype .'}]}]}, {'start':(7, 0), 'end':(7, 18), 'text':'The respective roles of PARVA and PARVB in this oncogenic role of ILK have not been fully characterized .'}]}, {'start':(8, 0), 'end':(8, 11), 'text':'PARVA has been shown to promote anti-apoptotic signaling from activated ILK .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 17), 'text':'In contrast , in breast cancer PARVB appears to be an inhibitor of ILK kinase [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 35), 'text':'In one recent study , PARVB mRNA and protein levels were found to be markedly downregulated in a number of advanced tumors , together with increases in ILK protein level and kinase activity [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 8), 'text':'Low PARVB levels correlated with low adhesion to collagen'}, {'start':(11, 9), 'end':(11, 31), 'text':'and restoring the levels of PARVB resulted in increased adhesion , and reversal of anchorage independent growth coincident with decreased ILK activity .'}]}, {'start':(12, 0), 'end':(12, 10), 'text':'In addition , overexpression of PARVB increases apoptosis [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 14), 'text':'The activating phosphorylation of Akt was reduced by increased levels of PARVB [ ] ,'}, {'start':(13, 15), 'end':(13, 27), 'text':'which may translate in increased susceptibility of the cancer cells to apoptosis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 6), 'text':'Another target of ILK is GSK3beta ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 7), 'end':(14, 14), 'text':'which can regulate nuclear accumulation of beta-catenin ,'}, {'start':(14, 15), 'end':(14, 20), 'text':'frequently observed in transformed cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 16), 'text':'Increased ILK activity leads to nuclear accumulation of beta-catenin and upregulation of TCF and LEF targets ,'}, {'start':(15, 17), 'end':(15, 31), 'text':'whereas restoring PARVB levels in cancer cells appears to downregulate nuclear beta-catenin [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 12), 'text':'This tumor-suppressive role of PARVB is consistent with deletions in the PARVB locus'}, {'start':(16, 13), 'end':(16, 16), 'text':'( 22q13 .21 )'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 17), 'end':(16, 20), 'text':'observed in some colon'}, {'start':(16, 21), 'end':(16, 26), 'text':'and breast cancers [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 22), 'text':'The PARVG gene was suspected to have a similar tumor suppressive role in a locus 12 Kb away ( 22q13 .31 ) ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(17, 23), 'end':(17, 29), 'text':'but no mutations were identified in colon'}, {'start':(17, 30), 'end':(17, 35), 'text':'and breast tumors [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 1), 'text':'Kidney disease'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 10), 'text':'ILK , PARVA and PINCH-1 are expressed in glomerular mesangial cells'}, {'start':(19, 11), 'end':(19, 15), 'text':'and podocytes [ ] .'}]}]}]}]}, {'start':(20, 0), 'end':(20, 21), 'text':'By mRNA differential display analysis , ILK was identified as a candidate gene in Finnish type congenital nephritic proteinuria [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 11), 'text':'ILK expression was found to be increased in glomeruli [ ] ,'}, {'start':(21, 12), 'end':(21, 25), 'text':'which could contribute to the increased matrix deposition in glomerulosclerosis in human patients .'}]}, {'start':(22, 0), 'end':(22, 14), 'text':'ILK is involved in mesangial cell matrix deposition in response to hyperglycemia [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 12), 'text':'In mesangial cells , the PINCH-1-ILK-PARVA complex locates to FAs and fibrillar adhesions'}, {'start':(23, 13), 'end':(23, 21), 'text':'where it promotes fibronectin matrix deposition [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 25), 'text':'Disruption of the PINCH-1-ILK-PARVA complex with ILK-C or ILK-N dominant negative mutants resulted in decreased cell proliferation , fibronectin synthesis and matrix deposition [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 30), 'text':'The levels of PINCH-1 , ILK and PARVA increase with podocyte differentiation , and the PINCH-1-ILK-PARVA complex plays a critical role in podocyte adhesion , architecture and survival [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 22), 'text':'In these cells , interference with the formation of the PINCH-1-ILK-PARVA complex by dominant negative ILK and PARVA constructs reduced podocyte adhesion ,'}, {'start':(26, 23), 'end':(26, 26), 'text':'spreading and survival .'}]}]}]}]}, {'start':(27, 0), 'end':(27, 21), 'text':'ILK also promotes upregulation of matrix metalloproteinase-9 ( MMP-9 ) mRNA levels and beta-catenin translocation during podocyte stress [ - ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 36), 'text':'In addition to its role in the glomerulus , ILK complexes play an important role in tubular cell epithelial to mesenchymal transition and interstitial fibrosis in response to TGF-beta , tubular obstruction or hyperglycemia [ ] .'}, {'start':(29, 0), 'end':(29, 10), 'text':'A dominant negative mutant of ILK largely reversed these effects .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(30, 0), 'end':(30, 23), 'text':'Given the important role of the ILK-PINCH1-PARVA complex in renal physiology and pathology , this complex is a potential target for therapeutic intervention ,'}, {'start':(30, 24), 'end':(30, 40), 'text':'provided that beneficial effects , such as podocyte adhesion and survival , are not significantly inhibited .'}]}]}]}]}
238	252	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 3), 'text':'Conclusions and Future Studies'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 2), 'text':'From the studies'}, {'start':(1, 3), 'end':(1, 7), 'text':'discussed in this review ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 8), 'end':(1, 10), 'text':'it is apparent'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 11), 'end':(1, 22), 'text':'that PARVA and PARVB play critical roles in several cell functions ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 23), 'end':(1, 31), 'text':'regulating cytoskeletal activity in connection with the ECM ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 32), 'end':(1, 40), 'text':'and that these functions are mediated by their ability'}, {'start':(1, 41), 'end':(1, 64), 'text':'to form complexes with key proteins at the different subcellular locations , such as FAs , lamellipodia , fibrillar adhesions and possibly nuclei .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 8), 'text':'In particular , the formation and regulation of complexes'}, {'start':(2, 9), 'end':(2, 58), 'text':'involving parvin , ILK and PINCH proteins as well as interactions with other ancillary proteins , such as Mig-2 [ ] , paxillin , ARHGEF6 , alpha-actinin and TESK1 , together with differential phosphorylation by Cdc2 , ERK and ILK , mediate the various effects of PARVA and PARVB .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 15), 'text':'Clearly , despite their high homology , different members of the parvin family have distinct functions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 16), 'end':(3, 19), 'text':'imparted by their ability'}, {'start':(3, 20), 'end':(3, 27), 'text':'to form alternative complexes and differential regulation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 5), 'text':'Table summarizes some of the features'}, {'start':(4, 6), 'end':(4, 10), 'text':'distinguishing the two parvins .'}]}, {'start':(5, 0), 'end':(5, 21), 'text':'Despite considerable progress , much remains to be investigated to clarify the roles of parvins in cell physiology and pathological processes .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 10), 'text':'For example , PARVG appears similar to PARVA and PARVB ,'}, {'start':(6, 11), 'end':(6, 16), 'text':'but as we have learned ,'}]}, {'start':(6, 17), 'end':(6, 24), 'text':'similar domains could mediate quite different effects .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 12), 'text':'Clarifying the role of PARVG , particularly in hematological cells and pathologies ,'}, {'start':(7, 13), 'end':(7, 21), 'text':'will be an interesting area of future research .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 32), 'text':'Further investigation on the various PINCH-ILK-parvin complexes and their binding proteins in different cell types under different stimulatory events should help us to elucidate the role of each complex in cell physiology .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 8), 'text':'Of particular interest is the elucidation of the mechanisms'}, {'start':(9, 9), 'end':(9, 26), 'text':'by which PARVA and PARVB regulate the activity of Rho family GTPases in the various cell types .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 3), 'text':'Searching for additional proteins'}, {'start':(10, 4), 'end':(10, 9), 'text':'interacting with the CH domains ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 10), 'end':(10, 26), 'text':'in particular the CH1 domain of PARVA and the CH2 of PARVB , should reveal additional details'}, {'start':(10, 27), 'end':(10, 38), 'text':'on how parvin proteins regulate cell spreading , motility and survival .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 12), 'text':'Undoubtedly , this field will continue to progress at a rapid pace .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 5), 'text':'Further interactions and cross talking pathways'}, {'start':(12, 6), 'end':(12, 14), 'text':'involving parvins and their partners will be uncovered .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 21), 'text':'Ultimately , only a comprehensive systems biology approach well grounded on experimental observation and powerful computational resources will be able to model'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 22), 'end':(13, 33), 'text':'and make reliable predictions about the functioning of this important complex network'}, {'start':(13, 34), 'end':(13, 43), 'text':'in transducing signaling between the ECM and the cell .'}]}]}]}]}]}]}
42	47	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'Tissue distribution'}, {'label':'contrast', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 9), 'text':'In mammalian organisms , PARVA and PARVB are ubiquitously expressed'}, {'start':(1, 10), 'end':(1, 17), 'text':'but enriched in heart and skeletal muscle .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 7), 'text':'In the spleen and platelets [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 8), 'end':(2, 16), 'text':'the predominant isoform of PARVB is a short form'}, {'start':(2, 17), 'end':(2, 25), 'text':'translated from a downstream initiation codon , PARVB-ss .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 7), 'text':'PARVG has a more restricted tissue distribution ,'}, {'start':(3, 8), 'end':(3, 27), 'text':'as determined from messenger RNA ( mRNA ) blots , with predominance of lymphoid and hematopoietic tissues [ ] .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 6), 'text':'Since currently there are no published studies'}, {'start':(4, 7), 'end':(4, 12), 'text':'addressing the functions of PARVG ,'}]}, {'start':(4, 13), 'end':(4, 23), 'text':'we will focus on PARVA and PARVB in our discussions .'}]}]}]}
